Search - tctmd.com

Displaying 881 - 900 of 8902

Sort: Relevancy | Date

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Presenter: Joshua Goldberg

June 07, 2024

Presentation NY Valves 2024

Assessing Functional Status and Predicting Clinical Improvement

Presenter: Suzanne V. Arnold

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

T-TEER - TRILUMINATE

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Presenter: Shephal K. Doshi

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Advertisement

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Assessing Functional Status and Predicting Clinical Improvement

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

T-TEER - TRILUMINATE

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content